128 related articles for article (PubMed ID: 36870059)
41. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
[TBL] [Abstract][Full Text] [Related]
42. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
[TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.
Hurbin A; Wislez M; Busser B; Antoine M; Tenaud C; Rabbe N; Dufort S; de Fraipont F; Moro-Sibilot D; Cadranel J; Coll JL; Brambilla E
J Pathol; 2011 Sep; 225(1):83-95. PubMed ID: 21598249
[TBL] [Abstract][Full Text] [Related]
44. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
[TBL] [Abstract][Full Text] [Related]
45. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
[TBL] [Abstract][Full Text] [Related]
46. Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma.
Yin H; Jing B; Xu D; Guo W; Sun B; Zhang J; Liao Y; Song H; Wang T; Liu S; Kuang Y; Hu M; Li K; Zhang S; Zhang H; Xu J; Li X; Du J; Wu Y; Wu Y; Wang Q; Yao F; Chin YE; Zhou BP; Deng J
Cancer Res; 2022 Mar; 82(6):1025-1037. PubMed ID: 35045987
[TBL] [Abstract][Full Text] [Related]
47. Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling.
McCauley KB; Hawkins F; Serra M; Thomas DC; Jacob A; Kotton DN
Cell Stem Cell; 2017 Jun; 20(6):844-857.e6. PubMed ID: 28366587
[TBL] [Abstract][Full Text] [Related]
48. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.
Si J; Ma Y; Bi JW; Xiong Y; Lv C; Li S; Wu N; Yang Y
J Exp Clin Cancer Res; 2019 Dec; 38(1):481. PubMed ID: 31801598
[TBL] [Abstract][Full Text] [Related]
49. TTF-1/Nkx2.1 functional connection with mutated EGFR relies on LRIG1 and β-catenin pathways in lung cancer cells.
Zamboni M; Civitareale D
Biochem Biophys Res Commun; 2018 Nov; 505(4):1027-1031. PubMed ID: 30314701
[TBL] [Abstract][Full Text] [Related]
50. Identification of novel human Wnt target genes using adult endodermal tissue-derived organoids.
Boonekamp KE; Heo I; Artegiani B; Asra P; van Son G; de Ligt J; Clevers H
Dev Biol; 2021 Jun; 474():37-47. PubMed ID: 33571486
[TBL] [Abstract][Full Text] [Related]
51. Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis.
Kadry YA; Lee JY; Witze ES
Open Biol; 2021 Oct; 11(10):210033. PubMed ID: 34610265
[TBL] [Abstract][Full Text] [Related]
52. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
[TBL] [Abstract][Full Text] [Related]
53. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
[No Abstract] [Full Text] [Related]
54. Derivation of a new model of lung adenocarcinoma using canine lung cancer organoids for translational research in pulmonary medicine.
Shiota Sato Y; Elbadawy M; Suzuki K; Tsunedomi R; Nagano H; Ishihara Y; Yamamoto H; Azakami D; Uchide T; Fukushima R; Tanaka R; Yoshida T; Mori T; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Aboubakr M; El-Asrag ME; Usui T; Sasaki K
Biomed Pharmacother; 2023 Sep; 165():115079. PubMed ID: 37413906
[TBL] [Abstract][Full Text] [Related]
55. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
[TBL] [Abstract][Full Text] [Related]
56. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma.
Yiming R; Takeuchi Y; Nishimura T; Li M; Wang Y; Meguro-Horike M; Kohno T; Horike SI; Nakata A; Gotoh N
Cancer Sci; 2021 Sep; 112(9):3810-3821. PubMed ID: 34145929
[TBL] [Abstract][Full Text] [Related]
57. Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
Lin Y; Higashisaka K; Shintani T; Maki A; Hanamuro S; Haga Y; Maeda S; Tsujino H; Nagano K; Fujio Y; Tsutsumi Y
Sci Rep; 2020 Mar; 10(1):4748. PubMed ID: 32179851
[TBL] [Abstract][Full Text] [Related]
58. Ubiquilin proteins regulate EGFR levels and activity in lung adenocarcinoma cells.
Kurlawala Z; Saurabh K; Dunaway R; Shah PP; Siskind LJ; Beverly LJ
J Cell Biochem; 2021 Jan; 122(1):43-52. PubMed ID: 32720736
[TBL] [Abstract][Full Text] [Related]
59. B7-H3-Induced Signaling in Lung Adenocarcinoma Cell Lines with Divergent Epidermal Growth Factor Receptor Mutation Patterns.
Ding M; Liao H; Zhou N; Yang Y; Guan S; Chen L
Biomed Res Int; 2020; 2020():8824805. PubMed ID: 33426073
[TBL] [Abstract][Full Text] [Related]
60. EGFR autophosphorylation but not protein score correlates with histologic and molecular subtypes in lung adenocarcinoma.
Moldvay J; Barbai T; Bogos K; Piurko V; Fillinger J; Popper HH; Tímár J
Diagn Mol Pathol; 2013 Dec; 22(4):204-9. PubMed ID: 24193009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
